Although traditionally considered to have limited efficacy in patients with diabetes, recent studies indicate that, when acting synergistically with GLP-1, GIP enhances insulinotropic effects and improves overall metabolic homeostasis (20, 21)
Yet, this promise is clouded by concerning headlines, FDA warnings about illegal salt forms, and a confusing online marketplace
16,18 Importantly, recent findings reveal a bidirectional interaction between the gut microbiota and the GLP-1/GLP1R axis, positioning this interface as a key mediator of metabolic regulation in childhood (Figure 2)
Semaglutide treatment at dosages from 0.5 mg to 2 mg weekly demonstrated variable efficacy, from preventing further weight gain in patient 1, to achieving weight loss of up to 14.4% and 11% relative to baseline, in Patient 2 and Patient 3
The most clinically significant concern is the potential for changes in moles or nevi, which requires regular dermatological monitoring during use
Victoza brought in 245m of sales for Novo Nordisk in the first three months of this year, down by 23% from a year earlier, while Saxendas first-quarter sales halved to 188m